
From the beginning until now, our dedication to excellence has been the mainstay of Sutcon Sutures’ journey. Starting in Indonesia in 2015 with the establishment of PT Efada Medical Industries Indonesia, we have always been committed to providing the best.
In 2018, the factory in Indonesia started production and launched its first product in December. The next big step occurred in 2019 when our products were listed in the LKPP E-catalog, expanding our access in the national medical device sector. In 2023, we successfully achieved HALAL certification and achieved more than 40% Domestic Component Level (TKDN), affirming our efforts in providing high-quality products with significant contributions to the local industry.
We offer a variety of sterile surgical suture and needle products with the best quality, complete with various options according to the needs of the action. In addition, we also support minor and major operations with full confidence in their quality and safety.


Hospital, Surgical Clinic

Distributor partnership

Other Health Institutions

Vision
Mission
Our Values

Best Performance
Specializing in high quality surgical sutures manufacturing

Quality Assurance
We adhere to strict regulatory and certification standards.

Focus On Customer
Dedicated to providing exceptional service and TKDN support

AKD Products
Dedicated to contributing to local economic growth

Surgical Success Begins here
Sutcon Sutures collaborates with German and British experts, bringing technological innovation in manufacturing sterile absorbable and non-absorbable surgical sutures and needles using USP & EP standards. As a local manufacturer in Indonesia with high Domestic Component Level (TKDN) value, we are the first choice in the medical industry.

Quality is Our Main Priority
Each product undergoes strict quality control with complete testing facilities, from chemical, microbiological, to instrumental tests. We ensure that every needle and surgical thread produced meets the requirements of the European Medical Device Directive, British Pharmacopoeia, and United States Pharmacopoeia.









